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Pittsburgh, Pennsylvania
To evaluate whether acute myocardial dysfunction was
common in the early postoperative period, serial hemody-
namic measurements and radionuclide evaluation of ven-
tricular function were performed before and after opera-
tion in 24 patients undergoing elective coronary bypass
surgery. All patients had uncomplicated surgery, and no
patient sustained an intraoperative infarction. In 96% of
patients, significant depression in right and left ventricular
ejection fraction was seen postoperatively, reaching a nadir
at 262 ± 116 min after coronary bypass. Left ventricular
ejection fraction was 58 ± 12% preoperatively and 37 ±
10% at trough. Right ventricular function displayed a
similar pattern. These findings were also associated with
depressed cardiac and left ventricular stroke work index
despite maintenance of adequate ventricular filling pres-
sures and mean arterial pressure.
The depression in ventricular function was partially
reversible within 8 to 10 h after surgery. Left ventricular
ejection fraction had increased to 55 ± 13% at 426 ± 77
Acute myocardial dysfunction has been suggested to be a
common occurrence after cardiopulmonary bypass, but its
time course and frequency have not been well established
0-4). It appears to be a reversible event within 24 h of
surgery and ma.y have profound importance in the early
postoperative period, especially in patients with already
compromised ventricular function. This may have an effect
on patient management and on the assessment of early
postoperative morbidity and mortality. Although its origin
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min after coronary bypass and showed complete recovery
within 48 h. Left ventricular end-systolic and end-diastolic
volume index increased significantly postoperatively, but
recovery in left ventricular ejection fraction was mostly due
to decreases in end-systolic volume index (50 ± 22 ml at
trough and 32 ± 16 ml at recovery). Depressed myocardial
function was independent of bypass time, number of grafts
placed, preoperative medications or core temperatures
postoperatively. Postoperative therapy with pressors or
inotropic agents delayed but did not prevent the occurrence
of postoperative ventricular dysfunction.
Despite improvements in operative techniques and
methods of myocardial protection, postoperative left ven-
tricular dysfunction continues to be common in patients
undergoing cardiopulmonary bypass surgery. Although the
mechanism of myocardial depression in the early postoper-
ative period is unclear, the results are suggestive of reper-
fusion injury.
(J Am Coil CardioI1990;15:1261-9)
remains unclear, some studies (5,6) have suggested that
inadequate myocardial protection or the effects of cold
cardioplegia may play a role. Recent studies (7-9) have
implicated reperfusion injury secondary to oxygen-derived
free radicals after cardiopulmonary bypass.
To further evaluate this process, serial hemodynamic and
radionuclide monitoring was utilized to assess right and left
ventricular function in the pre- and postoperative period in 24
patients undergoing elective uncomplicated coronary bypass
surgery. This approach was used to determine how frequently
biventricular dysfunction occurred, assess its reversibility
and define the role of routine postoperative therapy.
Methods
Study patients. Twenty-four patients undergoing routine
elective coronary bypass surgery completed the study. Pa-
0735·1097/90/$3.50
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Table 1. Clinical Data in 24 Patients
Ca = calcium channel; CPB = cardiopulmonary bypass; postop =
postoperatively; Preop = preoperative; numbers in parentheses indicate
patient number; numbers to the right of ± signs indicate standard deviation.
tients undergoing repeat coronary surgery as well as those
with unstable angina or concurrent valve repair or aneurysm
resection were excluded. Five patients who initially signed
informed consent were excluded; one had an extensive
intraoperative myocardial infarction, three had a poor radio-
nuclide tag and one had inadequate positioning with the
nuclear probe. There were 19 men and 5 women, with a
mean age of 63 ± 11 years. Preoperative medical therapy is
indicated in Table 1; all patients were on antianginal therapy.
The mean number of grafts placed was 3.2 ± 0.9, with a
57 ± 18 min ischemic time and a 105 ± 26 min cardiopulmo-
nary bypass time. All patients enrolled in the study gave
informed consent. The study was approved by the Institu-
tional Review Board of Biomedical Research and Radiation
Safety Committee.
Pre- and intraoperative evaluation. All patients had radio-
nuclide angiography and nuclear probe studies performed
preoperatively to determine baseline ejection fraction and
regional wall motion and to correlate the gamma camera and
nuclear probe findings. The best left anterior oblique view
for evaluating the left ventricular region of interest was also
assessed. Labeling was performed with 25 mCi of techne-
tium pertechnetate by the modified in vivo labeling tech-
nique (10). Three view-gated blood pool studies were per-
formed with a mobile GE Starcam. Ejection fraction was
calculated in the "best septal" left anterior oblique view as
a 32 frame study, with 250,000 counts obtained per frame.
The ventricular region of interest was identified with a
semiautomated edge detection program that used both sec-
Mean age (yr)
No. of grafts
Ischemic time (min)
CPB time (min)
Preop medications (no. of patients)
Nitrates
Beta-blockers
Ca antagonists
Core temperature (ec)
Immediately postop
Trough
Recovery
Therapy received within 8 h of CPB
(no. of patients)
None
Dobutamine
Dopamine
Nipride
Nitroglycerin
Neosynephrine
63 ± II
3.2 ± 0.9
57 ± 18
105 ± 26
13 (I. 2. 5, 8-10. 12-14, 18.20.22,23)
15 (I. 3. 5. 6. 8-12. 14, 18-21. 24)
19 (I, 3-5, 7-9, 11-20, 22. 23)
36 ± 0.7
36.7 ± 1.0
37.2 ± 0.8
7 (6. 7. 9. 16.21. 22. 24)
II (1-3. 5, 11-14, 17. 18.20)
9 (4, 5. 8, 10. 12, 14, 15, 18. 20)
9 (1.3,5. ll. 13, 14. 18, 19,23)
4 (13,17,20.23)
2 (2, 18)
ond derivative and threshold techniques. Ejection fraction
determination also relied on the use of periventricular back-
ground subtraction and a variable region of interest. Nuclear
probe studies were performed with the NIC II (Bios), which
is a high temporal resolution (10 ms) nonimaging device
(11-13). All studies were performed for 60 s, and background
activity was determined in both a manual and automatic
mode. All probe studies were performed by one operator
who had great proficiency with this device.
Before surgery, a right ventricular ejection fraction cath-
eter was placed in the pulmonary artery. This fast response
thermodilution catheter (REF I-Baxter Edwards) uses an
onboard computer to exponentially fit the thermodilution
output curve so that right ventricular volumes and right
ventricular ejection fraction can be determined (14,15).
Thermodilution right ventricular ejection fraction with this
technique correlates well with contrast and radionuclide
ventriculography over a wide range of ejection fractions,
however, in patients with significant tricuspid regurgitation,
a wide range of error can be seen (16). Other hemodynamic
measurements recorded included heart rate, right atrial
pressure, pulmonary artery pressure, pulmonary capillary
wedge pressure and mean systemic arterial pressure. Car-
diac output and right ventricular ejection fraction were
determined with iced dextrose in water in triplicate at 15 min
intervals pre- and intraoperatively by an experienced user of
this catheter. The three measurements were averaged if they
were within 10% of each other; curves judged to be "bad"
by the computer were excluded.
Postoperative evaluation. Within 131 ± 13 min after car-
diopulmonary bypass, patients arrived in the surgical inten-
sive care unit and were again labeled with 25 mCi of
technetium pertechnetate. The nuclear probe was positioned
over the left ventricular region of interest, and serial deter-
minations of left ventricular ejection fraction and filling
variables were recorded. Nuclear probe and hemodynamic
measurements were obtained serially at 15 min intervals for
up to 10 h (mean 8.8 ± 0.8) after operation. An automated
background approach was utilized with the nuclear probe
(78% of end-diastolic counts), but background was re-
checked manually and recorded at hourly intervals during
the study. Repeat radionuclide angiograms were performed
within 4 h of surgery and at 24 to 48 h postoperatively. Serial
hemodynamic assessment included systolic and diastolic
blood pressure, as well as all preoperative measurements
recorded together with right ventricular ejection fraction and
cardiac output. Other variables recorded included core tem-
peratures, arterial oxygen saturation and concordant medi-
cal therapy (including pressors and vasodilators (Table 1).
Left ventricular volumes, and stroke work index and sys-
temic vascular resistance were calculated from the recorded
measurements. No patient required intraaortic balloon coun-
terpulsation to come off cardiopulmonary bypass. All pa-
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tients had serial electrocardiograms and cardiac enzymes
determined for 48 h postoperatively.
Statistics. All data are displayed as mean values ± SD.
Each patient served as his or her own control from preoper-
ative to postoperative measurements. Comparisons between
pre- and postoperative variables were evaluated with a t test.
Analysis of variance for repeated measures was used to test
differences between serial measurements for a given variable
postoperatively. If differences were found. a paired Stu-
dent's t test was used to determine significance at p < 0.05.
Radionuclide angiograms were read by an independent ob-
server with no knowledge of the patients' hemodynamic or
nuclear probe results.
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than left ventricular ejection fraction before operation (52 ±
9%), but postoperative changes in right ventricular ejection
fraction paralleled those in the left ventricle (Table 2). In the
initial postoperative period, right ventricular ejection frac-
tion was mildly depressed (45 ± 11%), but at the time of
maximal left ventricular depression, it had decreased to 36 ±
14%. In 12 patients, left and right ventricular trough values
occurred at the same time, and in 9 additional patients, they
were within 30 min of each other. Recovery of right ventric-
Figure 1. Patient 3. Hemodynamic biventricular ejection fraction
responses. Shown from top to bottom are cardiac index (CI), mean
arterial pressure (MAP), right ventricular ejection fraction (RVEF)
and left ventricular ejection fraction (LVEF). This patient was
treated with dobutamine and nitroprusside shortly after surgery and
initially had a well preserved cardiac index. Right and left ventric-
ular ejection fraction were depressed in the early postoperative
period. but continued to worsen, reaching a nadir at 304 min after
cardiopulmonary bypass (CPB). This was associated with a signifi-
cant decrease in cardiac index. Significant recovery in all postoper-
ative variables was seen at 515 min after cardiopulmonary bypass.
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Results
Cardiac bypass surgery was uncomplicated in the 24
patients studied, with no patient having a intraoperative
myocardial infarction based on standard criteria (17). Inter-
mittent blood cardioplegia was used for all patients intraop-
eratively and did not change during the course of the study.
Therapy received postoperatively, number of grafts, ische-
mic time and core temperatures are indicated (Table 1).
Sixty-three percent of patients were placed on dopamine or
dobutamine within 8h of cardiopulmonary bypass; only 29%
required no therapy with vasopressors, inotropic agents or
vasodilators. All therapeutic decisions concerning postoper-
ative patient management were made by the cardiothoracic
or critical care fellows, independent of the ejection fraction
data recorded.
Depression and recovery of biventricular function (ejection
fraction response). Left ventricular ejection fraction was
depressed in the immediate postoperative period in 19 (79%)
of the 24 patients approximately 2 h after cardiopulmonary
bypass. In 4 additional patients, the decrease in left ventric-
ular ejection fraction was delayed, and in 23 of 24 patients, it
continued to worsen, reaching a nadir (trough level) at 262 ±
116 min after cardiopulmonary bypass (Fig. 1, Table 2). The
decline in left ventricular ejection fraction was highly signif-
icant, with a preoperative mean value of 58 ± 12%, decreas-
ing to 46 ± 12% immediately postoperatively and 37 ± 10%
at trough. One patient (Patient 4) had an increase in left
ventricular ejection fraction in the immediate postoperative
setting and despite a subsequent decline, it never decreased
to below preoperative levels. Significant recovery of left
ventricular ejection fraction to 55 ± 13% occurred in all
patients during the 8 to 10 h study (426 ± 77 min after
cardiopulmonary bypass). Full recovery of left ventricular
function was seen in all patients at the time of the 24 to 48 h
gated blood pool study. Correlation of nuclear probe and
radionuclide angiographic studies was very good (r = 0.92,
SEE ± 5) for pre- and postoperative studies over a wide
range of ejection fraction.
Right ventricular ejection fraction was somewhat lower
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Table 2. Pre- and Postoperative Ventricular Function in 24 Patients Undergoing Uncomplicated Coronary Bypass Surgery
Pt.
No.
I
2
3
4
5
6
7
8
9
10
II
12
13
14
15
16
17
18
19
20
21
22
23
24
Mean
±SD
Preop
LVEF RVEF CI LVEF
66 72 2.62 54
45 53 3.43 34
55 52 3.12 42
43 51 2.85 56
64 56 2.51 56
42 48 1.64 34
66 49 3.45 34
49 49 2.82 49
70 64 2.04 48
57 66 3.72 55
73 51 2.81 51
61 40 74
52 56 2.54 30
48 55 3.13 23
57 42 2.16 54
84 61 2.47 53
51 52 2.56 44
40 54 2.87 32
42 43 2.51 34
57 55 3.26 48
60 29 2.65 44
80 57 3.07 44
69 47 3.27 63
67 51 2.59 53
58 52 2.8 46
12 9 0.6 12
Immed Postop
Time
Post
RVEF CI CPB
53 6.05 135
34 2.55 145
41 3.63 160
50 4.38 130
62 2.34 142
25 1.72 139
34 1.75 123
38 3.34 145
60 2.43 130
57 3.69 150
55 2.58 130
37 2.81 135
46 1.98 105
52 2.46 120
60 4.36 120
26 2.06 140
43 2.29 120
40 3.67 123
39 2.31 120
50 2.25 121
39 2.21 125
47 2.06 115
62 3.89 127
39 2.69 140
45 2.9 131
II 1.0 13.0
LVEF
48
26
32
43
38
33
34
37
48
24
39
32
26
19
31
46
39
17
34
42
44
44
47
55
37
10
Trough
Time Post
CPH to LV
RVEF CI Trough
29 4.00 288
23 1.86 233
32 2.16 305
33 3.80 398
61 1.70 282
24 1.70 154
34 1.76 123
41 3.29 285
60 2.43 150
49 3.07 438
43 2.34 249
20 1.35 350
34 2.99 150
58 2.04 147
42 3.08 465
13 1.88 480
36 1.84 225
5 1.64 408
39 2.31 120
33 2.08 324
39 2.21 125
47 2.06 115
46 3.42 212
33 2.71 260
36 2.4 262
14 0.7 116
Recovery
LVEF RVEF CI
60 35 5.05
33 50 3.75
46 47 3.41
50 48 4.86
52 55 1.69
46 41 2.10
58 44 3.25
55 43 3.23
54 52 3.10
44 50 4.49
66 54 3.80
53 33 2.56
44 47 2.93
39 58 3.40
63 62 6.00
76 33 4.16
53 42 3.36
34 17 2.96
48 32 2.95
55 51 2.71
81 52 3.91
80 51 3.39
58 49 3.77
77 44 3.35
55 45 3.5
13 10 0.9
Time Post
CPH to LV
Recovery
423
383
515
518
312
469
378
450
451
543
474
410
420
477
495
510
375
468
225
444
365
400
437
290
426
77
CI =cardiac index (liters/min per m2); CPH =cardiopulmonary bypass (min); Immed = immediately; LV =left ventricular; LVEF =left ventricular ejection
fraction (%); Post = after; Postop = postoperatively; Preop = preoperatively; PI. = patient; RVEF = right ventricular ejection fraction (%).
ular function displayed a similar pattern as that of the left
ventricle and was almost complete in patients at 8 to 10 h
after cardiopulmonary bypass (45 ± 10% at recovery) and
showed full recovery by 24 h as judged by radionuclide
angiography. Depression and recovery of right and left
ventricular function were independent of patients' core
temperature or hemodynamic profile but were somewhat
related to therapy received.
Hemodynamic changes after cardiopulmonary bypass.
Preoperative mean arterial pressure (86 ± 10 mm Hg) and
ventricular filling pressures (pulmonary capillary wedge
pressure [13 ± 3 mm Hg] and central venous pressure [7 ±
2 mm Hg]) were maintained in patients postoperatively when
possible, with fluids or supportive medications (Table 3).
Heart rate increased from a 66 ± II beats/min preoperatively
to 96 ± 20 beats/min postoperatively and remained relatively
constant during the postoperative portion of the study.
Cardiac index, although initially stable in the postoperative
period (2.9 ± 1.0 liters/min per m2), decreased significantly
at the nadir of left ventricular function (2.4 ± 0.7 liters/min
per m2), but increased beyond preoperative levels (3.5 ± 0.9
liters/min per m2) at recovery (Table 2). This increase
beyond baseline values may be a reflection of the number of
patients placed on inotropic or vasodilator therapy. Changes
in left ventricular volumes suggested that significant systolic
left ventricular dysfunction occurred in the postoperative
period (left ventricular end-systolic volume index increased
from 39 ± 21 ml immediately after operation to 50 ± 22 ml at
the nadir in the left ventricular ejection fraction). At recov-
ery, there was a significant decrease in left ventricular
end-systolic volume index to 32 ± 16 ml (p = 0.003).
Changes in left ventricular end-diastolic volume index were
also significant from immediate postoperative to trough
levels, but the major improvement in left ventricular ejection
fraction at recovery reflected significant decreases in end-
systolic volume index. Left ventricular stroke work index
was depressed postoperatively (33 ± II g-rn/m2) and contin-
ued to worsen at trough levels of ventricular function (29 ±
13 g-m/m2). At recovery, there was an improvement in left
ventricular stroke work index (37 ± 9 g-m/m2, p = 0.02),
although it still remained below normal preoperative levels.
Systemic vascular resistance index was unchanged initially
S:'-
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Table 3. Postoperative Hemodynamic Assessment of Left Ventricular Function in 24 Patients
PI.
Immed Postop Trough Recovery
No. LVEDVI LVESVI LVSWI HR MAP PCWP LVEDVI LVESVI LVSWI HR MAP PCWP LVEDVI LVESVI LVSWI HR MAP PCWP
1 122 56 58 91 77 16 92 48 67 90 118 14 78 31 58 108 100 15
2 79 52 27 96 79 10 81 60 18 90 74 10 103 69 38 110 85 14
3 81 47 38 108 89 II 88 60 30 77 90 14 98 53 36 80 70 10
4 84 37 52 94 90 11 86 49 37 104 84 12 88 44 44 110 79 10
5 61 27 27 69 72 15 63 39 22 71 78 12 44 21 25 72 84 13
6 68 45 27 76 94 12 67 45 25 76 91 12 57 31 24 80 75 12
7 82 54 26 62 72 10 82 54 26 62 72 10 67 28 37 84 78 11
8 76 39 31 91 72 13 100 63 33 88 72 12 62 28 29 96 73 II
9 63 33 30 80 74 6 63 33 30 80 74 6 63 29 34 90 81 12
10 60 27 35 112 82 9 100 76 21 126 70 12 82 46 31 124 71 11
11 43 21 28 116 94 10 51 31 25 116 100 9 62 21 45 92 87 13
12 32 8 20 118 67 8 50 34 17 87 89 13 51 24 30 96 93 13
13 80 56 33 82 102 10 112 83 43 104 117 13 66 37 41 100 108 10
14 135 104 43 80 112 10 137 III 37 80 106 8 105 64 48 82 86 7
15 70 32 33 116 69 9 94 65 18 106 56 12 76 28 44 126 77 14 s:-<
16 38 18 22 104 86 8 43 23 16 94 68 11 49 12 45 112 95 10 0n
17 39 22 15 132 73 10 46 28 15 104 73 12 53 25 31 118 94 16 >:o:l
18 91 62 26 125 77 15 88 73 14 108 83 18 75 49 24 118 80 12 0
19 103 68 56 66 121 10 103 68 56 66 121 10 75 39 30 82 68 10 ~
20 56 29 31 82 90 II 62 36 25 80 80 13 64 29 35 77 82 12
."c
21 43 24 28 116 115 14 43 24 27 116 115 14 48 9 31 101 72 16 z
22 61 34 30 76 88 10 61 34 30 76 88 10 46 9 44 92 95 II 90
23 51 19 45 122 106 8 66 35 38 109 94 8 57 24 30 115 74 8 z
24 57 27 40 89 107 15 56 25 33 88 83 10 52 12 48 84 98 14 >~
Mean 70 39 33 96 88 11 76 50 29 92 87 12 68 32 37 98 84 12
m
:o:ltl:l
±SD 26 21 11 20 16 3 24 22 13 17 18 3 18 16 9 16 11 3 tl:l:o:l-<t!l
""til
HR = heart rate (beats/min); LVEDVI = left ventricular end-diastolic volume index (ml/m2); LVESVI = left ventricular end-systolic volume index (ml/m2); LVSWI = left ventricular stroke work index >tl:ltilt""
(g-m/m2); MAP = mean arterial pressure (mm Hg); PCWP = pulmonary capillary wedge pressure (mm Hg); other abbreviations as in Table 2. til>~:j
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Table 4. Role of Concordant Therapy in the Timing of Ventricular Dysfunction Postoperatively
Group I (n = 9) Group 2 (n = 15)
No Pressors Required Pressor or Inotropic Therapy
Time Post
LVEF p Value RVEF p Value ePB LVEF p Value RVEF p Value
Preop 64 ± 15 50 ± 10 55 ± 9 54 ± 8
0.006 0.08 NS 0.06
Postop 45 ± 10 41 ± 13 129 ± II 47 ± 13 48 ± 9
NS NS 0.002 0.009
Trough 43 ± 8 37 ± 14 193 ± 18 33 ± 9 36 ± 14
0.001 NS 0.001 0.03
Recovery 64 ± 14 44 ± 8 392 ± 90 50 ± 10 46 ± 11
p < 0.05 (significant) reflects differences between the two associated measurements. Abbreviations as in Table 2.
Time Post
ePB
132 ± 14
303 ± 96
447 ± 62
after operation (2,320 ± 380 preoperatively versus 2,443 ±
948 dyne.s.cm-5.m2 postoperatively), but at maximal left
ventricular depression, it increased to 2,780 ± 902
dyne.s.cm-5.m2 • At recovery, there was a highly significant
improvement in systemic vascular resistance index to 1,808
± 568 dyne.s.cm- 5.m2, which may reflect therapy received
and the normal vasodilatory response seen after surgery.
Radionuclide angiography. Postoperative radionuclide
angiograms were performed in both a left anterior oblique
and anterior view within 4 h of cardiopulmonary bypass in 20
patients and at 24 to 48 h in all patients. Postoperative
studies correlated with the nuclear probe studies and were
helpful in evaluating changes in left and right ventricular
function. No patient developed a new regional wall motion
abnormality in the postoperative period. In nine patients, the
initial postoperative radionuclide angiogram was performed
when there was no significant difference between the pre-
operative and postoperative nuclear probe ejection fraction
and the only new finding was paradoxic septal motion. In II
patients, the postoperative study demonstrated diffuse left
ventricular hypokinesia, paradoxic septal motion and, in 6
patients, left ventricular dilation. In II patients, right ven-
tricular function was assessed as normal on the radionuclide
study, but in 9 patients, right ventricular dilation and marked
hypokinesia were also present. The 24 to 48 h study in all
patients showed full recovery of left ventricular function,
and in six patients, there was improvement beyond preoper-
ative ejection fraction levels. Right ventricular function was
assessed as normal in all patients at the 24 to 48 h study.
Timing of left ventricular dysfunction and the role of
concurrent therapy. Of the 24 patients, 7 received no post-
operative medication and 2 received only intravenous nitro-
glycerin or nitroprusside (Group I). The remaining 15 pa-
tients required pressor or inotropic therapy (Group 2) during
the initial postoperative period, but both groups had normal
baseline left ventricular function (Table 4). Patients in Group
1 had a higher preoperative ejection fraction than did pa-
tients in Group 2 (Group I 64 ± 15% versus Group 2 55 ±
9%, p = 0.08), but no patient in either group had a baseline
left ventricular ejection fraction <40%, and only one patient
in Group 1 and six patients in Group 2 had an ejection
fraction <50%. Patients in Group 1 reached trough ejection
fraction levels significantly earlier in the postoperative pe-
riod (Group 1 193 ± 18 min versus Group 2 303 ± 96 min,
p = 0.02). Both groups manifested similar degrees of left
ventricular dysfunction during the study (33% versus 40%
decrease in ejection fraction in Group 1 and Group 2,
respectively), but early postoperative ventricular dysfunc-
tion was less marked in Group 2patients receiving pressor or
inotropic therapy. Its occurrence, however, could not be
prevented by therapy, only delayed. Significant recovery
toward baseline occurred in both groups over the same time
period despite different therapies received (Group 1392 ± 90
min versus Group 2 447 ± 62 min, p = NS). Depression and
recovery of right ventricular function displayed a similar
pattern in both groups. There were no differences .between
groups with respect to patient characteristics, preoperative
therapy, core temperature, number of coronary grafts or
aortic cross-clamp time.
Discussion
Despite improvements in surgical technique, methods of
cardioplegia and intraoperative anesthesia and monitoring,
acute myocardial dysfunction continues to be a common
problem early after elective coronary bypass surgery, as
seen in 96% of patients who were serially evaluated before
and after operation in this study. Although myocardial
dysfunction was reversible within 8 to 10 h of surgery, with
complete recovery of ventricular function by 48 h, its
occurrence in the majority of patients raises concerns.
Previous studies. Previous studies by Roberts et al. (l,2)
showed that 90% of their patients (36 of 40) displayed a
significant decrease in left ventricular ejection fraction
within 2 h of bypass surgery (50 ± 3% preoperatively to 38 ±
2% postoperatively), with full recovery occurring by 24 h.
This occurred despite myocardial protection with multidose
hypothermic potassium crystalloid cardioplegia, and was
lACC Vol. 15, No.6
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associated with a significant decrease in cardiac index and
left ventricular stroke work index. At 7 days, ejection
fraction increased in their patients beyond preoperative
levels. Similar studies by Gray et al. (3) showed identical
changes in cardiac index and left ventricular stroke work
index. Left ventricular ejection fraction in their patients
decreased from 58% preoperatively to 41% in the early
postoperative period; by day 2, ejection fraction had in-
creased to 61%. Response to volume infusion in the early
postoperative period showed flattening and downward dis-
placement of ventricular function curves in 23 of 30 patients,
suggesting depression of global left ventricular performance.
As in our study, left ventricular filling pressures were
maintained in all patients, and the depressed cardiac index
and left ventricular ejection fraction appear to represent a
decrease in contractility. In their study as well as ours,
systemic vascular resistance index did not significantly
change in the early postoperative period and excessive
afterload could, therefore, not explain the impressive de-
creases in ejection fraction.
Using gated cardiac blood pool imaging Reduto et al. (4)
compared the effects of normothermic intermittent ischemic
arrest versus cardioplegia in 57 patients undergoing aorto-
coronary bypass surgery, Early in the postoperative period,
six sequential nuclear studies were performed at 30 min
intervals, and significant left ventricular dysfunction (which
was normal by 1week) was seen in 46% of their patients, In
their study, left ventricular dysfunction was not observed as
often as in some of the other studies, but was found to be
independent of the form of myocardial protection used,
Mangano (18) noted myocardial dysfunction in all 22 patients
evaluated in the early postoperative period. By constructing
ventricular function curves and altering preload, left and
right ventricular dysfunction occurred early after revascu-
larization but was transient, showing significant recovery
within 4 h. As observed by us and others, Mangano (18) also
found that recovery of ventricular function was complete in
most patients within 24 h of surgery, Thus, it appears that
both right and left ventricular dysfunction occur commonly
after coronary bypass surgery. This is also supported by the
data from the right ventricular ejection fraction catheter used
in our study, as well as the radionuclide angiograms that
demonstrated the presence of right ventricular dilation and
hypokinesia.
Factors associated with postoperative ventricular dysfunc-
tion. Not all studies have demonstrated significant myocar-
dial dysfunction after cardiac surgery. The difference may be
related to how and when patients were studied, methods of
cardioplegia used and therapy in the postoperative setting
(19-21). A number offactors could be related to the marked
depression in ejection fraction observed after cardiopulmo-
nary bypass surgery. Czer et al. (9) and Fremes et al. (20)
suggested that there may be a temperature dependence to
the transient changes in ventricular function after bypass
surgery. During the period of myocardial rewarming, ejec-
tion fraction and myocardial metabolism recovered slowly
when cold crystalloid cardioplegia was used. Blood car-
dioplegia appeared to cause less ischemic injury and was
associated with better functional recovery, Myocardial tem-
peratures were consistently warmer with blood cardioplegia,
and no consistent temperature dependence was associated
with changes in ventricular function. In the present study,
core temperatures were improving as myocardial function
continued to worsen, suggesting an unlikely role of temper-
ature,
The method of cardioplegia used and the manner in
which it is given may play a role in the development of
postoperative ventricular dysfunction. Clinical studies com-
paring blood versus crystaloid cardioplegia have suggested
that blood cardioplegia may cause less ischemia injury, but
recently this has been brought into question (20-25), Mullen
et al. (24) found less perioperative ischemic injury with blood
cardioplegia, but postoperatively there were no differences
in ventricular performance between blood and crystaloid
cardioplegia. Other studies (25) have suggested that the
temperature of the blood may be important because, com-
pared with colder solutions, blood cardioplegia> 10°C pro-
vided decreased myocardial protection, In the present study,
blood cardioplegia was chilled to 3°e. Whether cardioplegia
is given intermittently or continuously, anterograde or in
retrograde manner through the coronary sinus may also have
an effect on ventricular function (26,27), Continuous blood
cardioplegia has been suggested (26) to be superior to either
intermittent blood or crystaloid cardioplegia in metabolically
protecting the hypertrophied human heart. Whether other
cardioplegic methods would have offered better myocardial
protection than that provided by the intermittent blood
cardioplegia in this study requires further investigation.
The assessment of ventricular loading conditions, both
preload and afterload, may also be important factors to
consider. Systemic vascular resistance index did not signif-
icantly change from preoperative to immediately postopera-
tive values, but did increase at trough left ventricular func-
tion, which could account for some of the depression in left
ventricular ejection fraction. This increase in systemic vas-
cular resistance index may be secondary to the depression in
left ventricular function and the need to maintain systemic
blood pressure. The confounding effect of pressor therapy
also needs to be considered. At recovery, systemic vascular
resistance index had dramatically improved to 1,808 ± 568
dyne.s.cm-5.m2, as might be expected with known vasodila-
tory response that occurs hours after operation; it may also
be related to the number of the patients receiving intrave-
nous nitroglycerin and nitroprusside. Pulmonary capillary
wedge pressure as a measure of preload may also be a
significant concern in the postoperative patient. As previ-
ously suggested (28,29), pulmonary capillary wedge pressure
traditionally used to evaluate left ventricular filling pressure
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may not be useful for assessing changes in left ventricular
end-diastolic volume in patients after cardiac surgery. Their
studies suggest that fluid therapy in such patients could
cause a substantial increase in left ventricular end-diastolic
volume, with minimal or no change in pulmonary capillary
wedge pressure. Other studies (30) indicate that fluid loading
after cardiopulmonary bypass can uncover left ventricular
dysfunction in the postoperative period. Whether this is
secondary to an open pericardium with overdistension of the
left ventricle, the use of positive end-expiratory pressure on
the ventilator or other factors is unclear. In the present
study, postoperative management was designed to maintain
a reasonable filling pressure of 10 to 15 mm Hg (pulmonary
capillary wedge pressure). but the increases seen in left
ventricular end-diastolic volume were not significant enough
to explain the degree of ventricular dysfunction.
Other studies (31) have suggested that the magnitude of
the early postoperative depression in left ventricular ejection
fraction correlated with the preoperative dose of beta-
adrenergic blocking agents that patients were receiving.
Those patients on higher doses of propranolol had a greater
decline in ejection fraction as assessed by a stepwise multi-
ple linear regression analysis. In the present study, preoper-
ative medication had no bearing on the observed results
because all patients were taking cardiac medication preoper-
atively and 66% were taking at least two drugs. Patients
receiving a beta-blocker did not demonstrate a greater
decline in ventricular function.
Proposed mechanism of ventricular dysfunction. Although
the mechanism of ventricular dysfunction in the postopera-
tive period remains unknown, some investigators have sug-
gested that reperfusion injury with oxygen free radicals may
playa role. In animal studies, Stewart et al. (32) demon-
strated that a cardioplegic solution containing superoxide
dismutase. a free radical scavenger, prevented metabolic
and functional abnormalities in left ventricular mechanics
that were routinely observed in a hypothermic global ische-
mic and reperfusion canine model. Similar studies (33,34) in
a Langendorff-perfused rabbit heart model with 30 min of
normothermic global ischemia suggest similar benefits with
the use of superoxide dismutase. Other animal studies
(35,36) using a regional coronary ischemia-reperfusion
model are equally suggestive that oxygen free radicals may
cause a depression in ventricular function. The timing of
ventricular dysfunction and recovery as seen in the present
study is similar to what has been suggested in animal models
of reperfusion injury (7,8).
Clinical implications and study limitations. The present
study demonstrates that early ventricular dysfunction after
coronary bypass surgery continues to be a common problem
despite current techniques of myocardial preservation. Se-
rial hemodynamic measurements and the evaluation of ven-
tricular function with the nonimaging nuclear probe and the
right ventricular ejection fraction catheter demonstrated that
global functional impairment of the right and left ventricles is
significant and time dependent in these patients. The use of
the nonimaging probe allowed continuous evaluation of
ventricular function, which not only predicted hemodynamic
deterioration in individual patients, but also indicated when
recovery would occur. This type of nonimaging technology
may have a role in evaluating patient status and in monitor-
ing early postoperative therapy. This study provides impor-
tant information as to the time course of these early postop-
erative events and the role that routine therapy may play.
Even though biventricular dysfunction was documented in
almost all patients postoperatively in this study, these ob-
servations were uncontrolled. In evaluating these patients,
many variables are impossible to assess, and differing post-
operative management styles may affect the degree to which
ventricular dysfunction is observed. The use of inotropic
agents, pressors and vasodilators may be common postop-
erative therapy in some centers, but rarely used in others.
Likewise, the role of maintaining ventricular filling pressures
(pulmonary capillary wedge pressure >10 mm Hg) could
affect the degree of ventricular dysfunction.
In the present study, the use of pressor or inotropic
agents appeared to delay the timing of left and right ventric-
ular dysfunction; however, all but one patient had a signifi-
cant depression in ejection fraction whether or not they were
used. One can argue whether ejection fraction should be
used to assess myocardial function because it is dependent
on both preload and afterload. and study measurements
were not made during altered loading conditions. In the
present study, however, the overwhelming evidence sug-
gests that the observed decreases in right and left ventricular
ejection fraction were due to transient myocardial dysfunc-
tion. The right ventricular ejection fraction catheter has its
own limitations, but when used for serial measurements. it
can demonstrate important trends in the evaluation of right
ventricular function.
This present study raises obvious questions about early
postoperative morbidity and mortality. Although the initial
postoperative course may have been more difficult to man-
age in some of these patients. no patient had an untoward
event. This study group included only patients undergoing
routine coronary artery bypass surgery who did not have
unstable angina, need for intraaortic balloon pump or pro-
longed operative time as might occur with a second bypass
procedure or concurrent valve replacement. One can only
speculate whether groups at higher risk would have greater
morbidity and mortality. In the past decade, improvements
in operative techniques and myocardial protection have
occurred, but transient myocardial dysfunction continues to
be a problem in patients undergoing cardiopulmonary by-
pass. Further studies are needed to evaluate the mechanism
of ventricular dysfunction in the early postoperative period
and to determine whether it can be prevented. We cannot
ascribe the results of this study or others to reperfusion
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injury, but there have been some suggestions that a role may
exist for free radical scavengers in protecting against this
form of postoperative myocardial depression, Future work
should be aimed in this direction.
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